Conversely, the influential technology space (-0.5%) shows the largest decline of the day. The space is being weighed down by large cap constituents like Microsoft (MSFT 51.35, -0.65), Facebook (FB 106.34, -2.06), and Alphabet (GOOGL 716.81, -13.41). like itThe three names have surrendered between 1.4% and 1.9% today. In the consumer discretionary space (-0.2%), heavyweight Amazon (AMZN 564.92, -10.22) weighs on the broader sector as the online retailer plunges 1.8% to begin its week. Meanwhile, fellow FANG name Netflix (NFLX 97.28, -4.30) has lost 4.2% after ITG Research offered cautious comments regarding the company’s domestic streaming estimates. Biotechnology demonstrates relative strength in the health care space (+0.9%). The ETF has surrendered 19.6% since the end of 2015, but has managed to climb 6.9% in March. Meanwhile the broader sector has gained 2.7% over that period. The Treasury complex has traded on its lows throughout the session. Currently, the yield on the 10-yr note is higher by four basis points at 1.91%. The U.S.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/stock-market-briefing-com-212642098.html
Dr Hou’s new chip and research findings were published earlier this year in Scientific Reports, a peer-reviewed scientific journal under the Nature Publishing Group. “Hopefully in future, clinicians can accurately tailor the right combination of drugs and thus offer a more targeted treatment approach for all diabetic patients,” added Dr Hou, the recipient of the inaugural Postdoctoral Fellowship offered by the medical school in 2014. Neutrophils as new biomarkers The NTU team discovered that neutrophils can be used as a biomarker to determine if diabetic patients are suffering from an inflammation. Using the new test kit, neutrophils can be easily extracted from a blood sample, and their behaviour and function observed for more efficient inflammation profiling in additional to the cell count. In healthy individuals, neutrophils float free in the blood stream. When there is an acute inflammation such as during a bacterial or viral infection, they will slow down and roll along the vessel walls. Once near the site of infection, they squeeze through the vessel walls and move to the site of the injury. In diabetic patients, the neutrophils roll faster, which means that fewer of them will manage to squeeze through the vessel wall to tackle the infection. The increased rolling speeds of neutrophils correlate closely with cholesterol and c-reactive protein levels (a biomarker for inflammation) so it provides doctors with a better indicator of an individual’s immune status, Dr Hou explained. The NTU team found that existing drugs prescribed to treat diabetes are able to change the rolling speed of neutrophils, in addition to controlling the blood sugar level.http://www.alabamascholars.org/carsonpetersonart/2016/09/21/2-and-from-not-having-to-listen-to-that-glorious-theme-song-that-i-can-no-longer-stand/
For the original version including any supplementary images or video, visit https://www.sciencedaily.com/releases/2016/09/160927082748.htm
You may also be interested to read
- Visit Your URL
- see here now